Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 Visningar
• 07/13/23
0
0
Bädda in
administrator
Prenumeranter
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna